AB Corporate Bond ETF (NASDAQ:EYEG) Short Interest Update

AB Corporate Bond ETF (NASDAQ:EYEG) saw a large decrease in short interest during the month of September. As of September 15th, there was short interest totaling 109 shares, a decrease of 89.5% from the August 31st total of 1,040 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 461 shares, the short-interest ratio is presently 0.2 days.

AB Corporate Bond ETF Trading Up 0.0%

NASDAQ EYEG traded up $0.01 during trading on Friday, hitting $33.65. The stock had a trading volume of 265 shares, compared to its average volume of 300. AB Corporate Bond ETF has a one year low of $33.64 and a one year high of $36.63. The stock has a 50 day simple moving average of $34.42 and a 200 day simple moving average of $34.94. The stock has a market capitalization of $26.92 million, a price-to-earnings ratio of -20.03 and a beta of 0.18. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.07 and a current ratio of 3.07.

AB Corporate Bond ETF Cuts Dividend

The firm also recently disclosed a monthly dividend, which was paid on Friday, September 4th. Investors of record on Tuesday, September 1st were issued a dividend of $0.1284 per share. This represents a $1.54 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date was Tuesday, September 1st. This is a decrease from AB Corporate Bond ETF’s previous monthly dividend of $0.1427. AB Corporate Bond ETF’s dividend payout ratio (DPR) is presently -101.79%.

AB Corporate Bond ETF Company Profile

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.